OX40 (CD134) and OX40 ligand, important immune checkpoints in cancer

Immunotherapy has shown promising results in cancer treatment. Research shows that most patients might be resistant to these therapies. So, new immune therapies are needed. OX40 (CD134) and OX40 ligand (OX40L), costimulatory molecules, express on different types of immune cells. The interaction betw...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Juan, Zhao, Sha, Zhang, Xiaoshen, Jia, Keyi, Wang, Hao, Zhou, Caicun, He, Yayi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735535/
https://www.ncbi.nlm.nih.gov/pubmed/31564917
http://dx.doi.org/10.2147/OTT.S214211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735535/
https://www.ncbi.nlm.nih.gov/pubmed/31564917
http://dx.doi.org/10.2147/OTT.S214211

Ejemplares similares